Loading...
Is CHEK2 a moderate-risk breast cancer gene or the younger sister of Li-Fraumeni?
The CHEK2 gene is mostly considered as a moderate breast cancer gene with the result that many clinicians have a narrow focus. We present the 10-year journey of a man who had five different cancers and had iterative genetic testing including for Li-Fraumeni syndrome, eventually to discover a pathoge...
Na minha lista:
| Udgivet i: | BMJ Case Rep |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7477966/ https://ncbi.nlm.nih.gov/pubmed/32900738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-236435 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|